disease-modifying therapies

2 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Researchandmarkets.Com

Dementia Drug Market Poised for Expansion as Disease-Modifying Therapies Reshape Treatment Landscape

Global dementia market expanding rapidly as disease-modifying treatments like LEQEMBI and KISUNLA shift focus from symptom management to early intervention for 55 million affected patients worldwide.
LLYBIIBESAIYALECmarket forecastAlzheimer's disease
GlobeNewswire Inc.GlobeNewswire Inc.··Researchandmarkets.Com

Alzheimer's Therapeutics Market Set to Exceed $6B by 2026 Amid Rising Investment

Alzheimer's therapeutics market projected to exceed $6B by 2026 driven by rising disease prevalence and increased pharma investment in disease-modifying treatments.
ABBVLLYNVORHHBYBIIBmarket growthAlzheimer's disease